ABSTRACT
Objective To study the correlation between the change of plasma homocysteine (Hcy)and fibrinogen(Fib)levels with the disease condition and prognosis in the patients with cerebral infarction(CI).Methods The plasma levels of Hcy and Fib were detected in 250 cases of cerebral infarction and 100 healthy adults(normal control,NC).All patients were evaluated on 1 d af-ter admission by NHISS,and after the 6-month follow-up by the modified Rankin scale.Results The levels of plasma Hcy and Fib in the CI group were significantly higher than those in the NC group(P <0.05);the levels of plasma Hcy and Fib in the NHISS se-vere patients were higher than those in the moderate and mild patients (P <0.05);the levels of plasma Hcy and Fib in the moderate patients were significantly higher than those in the mild patients (P <0.05).The good prognosis rate the low Hcy and Fib group was significantly higher than that in high Hcy and Fib group (P <0.05).Conclusion The levels of plasma Hcy and Fib are signifi-cantly increased in the patients with CI,and the increase in the severe patients is more significant.The patients with increased plas-ma Hcy and Fib levels have relatively poor prognosis.
ABSTRACT
Objective:To study the protective effect of Huangqi Injection on cardiotoxicity induced by doxorubicin (DOX) and its mechanism. Methods: The molders of Dox-induced myocardial mitochondria damage of rat in vitro and Dox-induced cardiotoxicity in mice were used. The protective effect of Huangqi Injection on cardiotoxicity induced by doxorubicin was determined by biochemical method.Results: Doxorubicin can increse malondialdehyde level, induce mitochondrin swelling and decrease glutathione (GSH) content of myocardial mitochondria of rat in vitro, while all these damages caused by doxorubicin were reduced significantly by Huangqi Injection. Cardiotoxicity of doxorubicin in mice as measured by increases of myocardial malondialdehyde level and serum creatine phosphokinase activity, decreases of superoxide dimutase was significantly alleviated by Huangqi Injection. Conclusions: Huangqi Injection can protect heart against Dox-induced cardiotoxicity, which provides experimental evidence for Huangqi Injection as an anti-tumor adjuvant drug in clinical application.